Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis

Journal of Infectious Diseases

Volumn 198, Issue 2, 2008, Pages 271-274

  Tucker, Erik I ^a   Gailani, David ^b   Hurst, Sawan ^a   Cheng, Qiufang ^a   Hanson, Stephen R ^a   Gruber, András ^a  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CONTROLLED STUDY; LIGATION; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PUNCTURE; SEPSIS;

ANIMALS; BLOOD COAGULATION; CECUM; FACTOR XI; FACTOR XI DEFICIENCY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONEAL DISEASES; PERITONITIS; PUNCTURES; REFERENCE VALUES; SEPSIS; SURVIVORS;

EID: 47649108101     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/589514     Document Type: Article

References (15)

1. Herwald H, Morgelin M, Olsen A, et al. Activation of the contact-phase system on bacterial surfaces - a clue to serious complications in infectious diseases. Nat Med 1998; 4:298-302.
2. Minnema MC, Friederich PW, Levi M, et al. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI: in vivo evidence for a role of factor XI as an anti-fibrinolytic factor. J Clin Invest 1998; 101:10-4.
3. Gruber A, Hanson SR. Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Blood 2003; 102:953-5.
4. Jalbert LR, Rosen ED, Moons L, et al. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest 1998; 102:1481-8.
5. Chan JC, Ganopolsky JG, Cornelissen I, et al. The characterization of mice with a targeted combined deficiency of protein c and factor XI. Am J Pathol 2001; 158:469-79.
6. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325:153-8.
7. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342:696-701.
8. Wang X, Cheng Q, Xu L, et al. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 2005; 3:695-702.
9. Kleinschnitz C, Stoll G, Bendszus M, et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 2006; 203:513-8.
10. Gailani D, Lasky NM, Broze GJ Jr. A murine model of factor XI deficiency. Blood Coagul Fibrinolysis 1997; 8:134-44.
11. Hubbard WJ, Choudhry M, Schwacha MG, et al. Cecal ligation and puncture. Shock 2005; 24(Suppl 1):52-7.
12. Clauss A. Rapid physiological coagulation method in determination of fibrinogen [in German]. Acta Haematol 1957; 17:237-46.
13. Ganopolsky JG, Castellino FJ. A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 2004; 165:1433-46.
14. Kalter ES, Daha MR, ten Cate JW, Verhoef J, Bouma BN. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 1985; 151:1019-27.
15. Pixley RA, De La Cadena R, Page JD, et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: in vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest 1993; 91:61-8.